BiocardiaInc Ownership
| BCDA Stock | USD 0.38 0.01 2.70% |
Shares in Circulation | First Issued 1996-09-30 | Previous Quarter 21.6 M | Current Value 23.7 M | Avarage Shares Outstanding 3.6 M | Quarterly Volatility 5.9 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
BiocardiaInc |
BiocardiaInc Stock Ownership Analysis
About 34.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.55. BiocardiaInc last dividend was issued on the 6th of June 2019. The entity had 1:9 split on the 6th of June 2019. BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart and Morph deflectable guides and sheaths. Biocardia operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people. For more info on BiocardiaInc please contact Peter Altman at 650 226 0120 or go to https://www.biocardia.com.Besides selling stocks to institutional investors, BiocardiaInc also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different BiocardiaInc's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align BiocardiaInc's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
BiocardiaInc Quarterly Liabilities And Stockholders Equity |
|
About 34.0% of BiocardiaInc are currently held by insiders. Unlike BiocardiaInc's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against BiocardiaInc's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of BiocardiaInc's insider trades
BiocardiaInc Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as BiocardiaInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BiocardiaInc backward and forwards among themselves. BiocardiaInc's institutional investor refers to the entity that pools money to purchase BiocardiaInc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Advisor Group Holdings, Inc. | 2023-12-31 | 21.4 K | State Street Corporation | 2023-12-31 | 21 K | Northern Trust Corp | 2023-12-31 | 19.2 K | Hrt Financial Llc | 2023-12-31 | 18.3 K | Wedbush Morgan Securities Inc | 2023-12-31 | 15 K | Pingora Partners Llc | 2023-12-31 | 7.4 K | Bank Of America Corp | 2023-12-31 | 6.5 K | Global Retirement Partners, Llc. | 2023-12-31 | 6.2 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 450 | Cm Management, Llc | 2023-12-31 | 700 K | Vanguard Group Inc | 2023-12-31 | 650.8 K |
BiocardiaInc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BiocardiaInc insiders, such as employees or executives, is commonly permitted as long as it does not rely on BiocardiaInc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases BiocardiaInc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jay Moyes over two weeks ago Acquisition by Jay Moyes of 12434 shares of BiocardiaInc at 4.43 subject to Rule 16b-3 | ||
Simon Stertzer over a month ago BiocardiaInc exotic insider transaction detected | ||
Simon Stertzer over six months ago Acquisition by Simon Stertzer of 12434 shares of BiocardiaInc subject to Rule 16b-3 | ||
Simon Stertzer over six months ago Acquisition by Simon Stertzer of 64212 shares of BiocardiaInc subject to Rule 16b-3 |
Pair Trading with BiocardiaInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BiocardiaInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiocardiaInc will appreciate offsetting losses from the drop in the long position's value.Moving against BiocardiaInc Stock
| 0.53 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.48 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.47 | NRSNW | NeuroSense Therapeutics | PairCorr |
| 0.46 | XFOR | X4 Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.44 | ELYM | Eliem Therapeutics | PairCorr |
The ability to find closely correlated positions to BiocardiaInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BiocardiaInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BiocardiaInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BiocardiaInc to buy it.
The correlation of BiocardiaInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BiocardiaInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BiocardiaInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BiocardiaInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BiocardiaInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.Note that the BiocardiaInc information on this page should be used as a complementary analysis to other BiocardiaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for BiocardiaInc Stock analysis
When running BiocardiaInc's price analysis, check to measure BiocardiaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiocardiaInc is operating at the current time. Most of BiocardiaInc's value examination focuses on studying past and present price action to predict the probability of BiocardiaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiocardiaInc's price. Additionally, you may evaluate how the addition of BiocardiaInc to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is BiocardiaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BiocardiaInc. If investors know BiocardiaInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BiocardiaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Revenue Per Share 0.023 | Quarterly Revenue Growth (0.88) | Return On Assets (1.14) | Return On Equity (7.04) |
The market value of BiocardiaInc is measured differently than its book value, which is the value of BiocardiaInc that is recorded on the company's balance sheet. Investors also form their own opinion of BiocardiaInc's value that differs from its market value or its book value, called intrinsic value, which is BiocardiaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BiocardiaInc's market value can be influenced by many factors that don't directly affect BiocardiaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BiocardiaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if BiocardiaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BiocardiaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.